世界のネオヘスピリジン市場予測 2023年-2029年

◆英語タイトル:Global Neohespiridine Market Growth 2023-2029

LP Informationが発行した調査報告書(LP23JU8250)◆商品コード:LP23JU8250
◆発行会社(リサーチ会社):LP Information
◆発行日:2023年5月
◆ページ数:111
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:化学&材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のネオヘスピリジン市場」は、過去の販売実績から2022年の世界のネオヘスピリジンの総販売量を検討し、2023年から2029年の予測されるネオヘスピリジンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のネオヘスピリジンの市場規模を掲載し、XXX百万米ドル規模の世界のネオヘスピリジン市場の詳細な分析を提供します。本インサイトレポートは、世界のネオヘスピリジン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のネオヘスピリジン市場における各社の独自のポジションをより深く理解するために、ネオヘスピリジン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のネオヘスピリジン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ネオヘスピリジンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。ネオヘスピリジンの中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ネオヘスピリジンのヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ネオヘスピリジンの世界主要メーカーとしては、DuPont、 Changsha Sunnycare、 Biospringer、 Gelfix、 CP Kelco、 Kang Biotech、 BASF SE、 Bordas Distillations Chinchurreta、 Golden Health、 Cargill、 Okay Pharmaceutical、 FMC Health and Nutrition、 Nutrafur、 Chr.Hansen Holding A/S、 Layn、 Corbion NV、 Hanfang、 Lianyuan Kangbiotech、 Firmenich SAなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のネオヘスピリジン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではネオヘスピリジン市場をセグメンテーションし、種類別 (工業用、食品用、薬局用)、用途別 (食品、医薬品、化学薬品、化粧品、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:工業用、食品用、薬局用

・用途別区分:食品、医薬品、化学薬品、化粧品、その他

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界のネオヘスピリジン市場の10年間の市場状況・展望は?
・世界および地域別に見たネオヘスピリジン市場成長の要因は何か?
・ネオヘスピリジンの市場機会はエンドマーケットの規模によってどのように変化するのか?
・ネオヘスピリジンのタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:ネオヘスピリジンの年間販売量2018-2029、地域別現状・将来分析
・ネオヘスピリジンの種類別セグメント:工業用、食品用、薬局用
・ネオヘスピリジンの種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・ネオヘスピリジンの用途別セグメント:食品、医薬品、化学薬品、化粧品、その他
・ネオヘスピリジンの用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のネオヘスピリジン市場
・企業別のグローバルネオヘスピリジン市場データ:2018-2023年の年間販売量、市場シェア
・企業別のネオヘスピリジンの年間売上:2018-2023年の売上、市場シェア
・企業別のネオヘスピリジン販売価格
・主要企業のネオヘスピリジン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ネオヘスピリジンの地域別レビュー
・地域別のネオヘスピリジン市場規模2018-2023:年間販売量、売上
・主要国別のネオヘスピリジン市場規模2018-2023:年間販売量、売上
・南北アメリカのネオヘスピリジン販売の成長
・アジア太平洋のネオヘスピリジン販売の成長
・ヨーロッパのネオヘスピリジン販売の成長
・中東・アフリカのネオヘスピリジン販売の成長

南北アメリカ市場
・南北アメリカの国別のネオヘスピリジン販売量、売上(2018-2023)
・南北アメリカのネオヘスピリジンの種類別販売量
・南北アメリカのネオヘスピリジンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のネオヘスピリジン販売量、売上(2018-2023)
・アジア太平洋のネオヘスピリジンの種類別販売量
・アジア太平洋のネオヘスピリジンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のネオヘスピリジン販売量、売上(2018-2023)
・ヨーロッパのネオヘスピリジンの種類別販売量
・ヨーロッパのネオヘスピリジンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のネオヘスピリジン販売量、売上(2018-2023)
・中東・アフリカのネオヘスピリジンの種類別販売量
・中東・アフリカのネオヘスピリジンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ネオヘスピリジンの製造コスト構造分析
・ネオヘスピリジンの製造プロセス分析
・ネオヘスピリジンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・ネオヘスピリジンの主要なグローバル販売業者
・ネオヘスピリジンの主要なグローバル顧客

地域別のネオヘスピリジン市場予測レビュー
・地域別のネオヘスピリジン市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ネオヘスピリジンの種類別市場規模予測
・ネオヘスピリジンの用途別市場規模予測

主要企業分析
DuPont、 Changsha Sunnycare、 Biospringer、 Gelfix、 CP Kelco、 Kang Biotech、 BASF SE、 Bordas Distillations Chinchurreta、 Golden Health、 Cargill、 Okay Pharmaceutical、 FMC Health and Nutrition、 Nutrafur、 Chr.Hansen Holding A/S、 Layn、 Corbion NV、 Hanfang、 Lianyuan Kangbiotech、 Firmenich SA
・企業情報
・ネオヘスピリジン製品
・ネオヘスピリジン販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

LPI (LP Information)’ newest research report, the “Neohespiridine Industry Forecast” looks at past sales and reviews total world Neohespiridine sales in 2022, providing a comprehensive analysis by region and market sector of projected Neohespiridine sales for 2023 through 2029. With Neohespiridine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neohespiridine industry.
This Insight Report provides a comprehensive analysis of the global Neohespiridine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neohespiridine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neohespiridine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neohespiridine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neohespiridine.
The global Neohespiridine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Neohespiridine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Neohespiridine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Neohespiridine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Neohespiridine players cover DuPont, Changsha Sunnycare, Biospringer, Gelfix, CP Kelco, Kang Biotech, BASF SE, Bordas Distillations Chinchurreta and Golden Health, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Neohespiridine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Industrial Grade
Food Grade
Pharmacy Grade
Segmentation by application
Food
Medicine
Chemical
Cosmetics
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
DuPont
Changsha Sunnycare
Biospringer
Gelfix
CP Kelco
Kang Biotech
BASF SE
Bordas Distillations Chinchurreta
Golden Health
Cargill
Okay Pharmaceutical
FMC Health and Nutrition
Nutrafur
Chr.Hansen Holding A/S
Layn
Corbion NV
Hanfang
Lianyuan Kangbiotech
Firmenich SA
Key Questions Addressed in this Report
What is the 10-year outlook for the global Neohespiridine market?
What factors are driving Neohespiridine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neohespiridine market opportunities vary by end market size?
How does Neohespiridine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neohespiridine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Neohespiridine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Neohespiridine by Country/Region, 2018, 2022 & 2029
2.2 Neohespiridine Segment by Type
2.2.1 Industrial Grade
2.2.2 Food Grade
2.2.3 Pharmacy Grade
2.3 Neohespiridine Sales by Type
2.3.1 Global Neohespiridine Sales Market Share by Type (2018-2023)
2.3.2 Global Neohespiridine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Neohespiridine Sale Price by Type (2018-2023)
2.4 Neohespiridine Segment by Application
2.4.1 Food
2.4.2 Medicine
2.4.3 Chemical
2.4.4 Cosmetics
2.4.5 Other
2.5 Neohespiridine Sales by Application
2.5.1 Global Neohespiridine Sale Market Share by Application (2018-2023)
2.5.2 Global Neohespiridine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Neohespiridine Sale Price by Application (2018-2023)
3 Global Neohespiridine by Company
3.1 Global Neohespiridine Breakdown Data by Company
3.1.1 Global Neohespiridine Annual Sales by Company (2018-2023)
3.1.2 Global Neohespiridine Sales Market Share by Company (2018-2023)
3.2 Global Neohespiridine Annual Revenue by Company (2018-2023)
3.2.1 Global Neohespiridine Revenue by Company (2018-2023)
3.2.2 Global Neohespiridine Revenue Market Share by Company (2018-2023)
3.3 Global Neohespiridine Sale Price by Company
3.4 Key Manufacturers Neohespiridine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neohespiridine Product Location Distribution
3.4.2 Players Neohespiridine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Neohespiridine by Geographic Region
4.1 World Historic Neohespiridine Market Size by Geographic Region (2018-2023)
4.1.1 Global Neohespiridine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Neohespiridine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Neohespiridine Market Size by Country/Region (2018-2023)
4.2.1 Global Neohespiridine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Neohespiridine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Neohespiridine Sales Growth
4.4 APAC Neohespiridine Sales Growth
4.5 Europe Neohespiridine Sales Growth
4.6 Middle East & Africa Neohespiridine Sales Growth
5 Americas
5.1 Americas Neohespiridine Sales by Country
5.1.1 Americas Neohespiridine Sales by Country (2018-2023)
5.1.2 Americas Neohespiridine Revenue by Country (2018-2023)
5.2 Americas Neohespiridine Sales by Type
5.3 Americas Neohespiridine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neohespiridine Sales by Region
6.1.1 APAC Neohespiridine Sales by Region (2018-2023)
6.1.2 APAC Neohespiridine Revenue by Region (2018-2023)
6.2 APAC Neohespiridine Sales by Type
6.3 APAC Neohespiridine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Neohespiridine by Country
7.1.1 Europe Neohespiridine Sales by Country (2018-2023)
7.1.2 Europe Neohespiridine Revenue by Country (2018-2023)
7.2 Europe Neohespiridine Sales by Type
7.3 Europe Neohespiridine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Neohespiridine by Country
8.1.1 Middle East & Africa Neohespiridine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Neohespiridine Revenue by Country (2018-2023)
8.2 Middle East & Africa Neohespiridine Sales by Type
8.3 Middle East & Africa Neohespiridine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neohespiridine
10.3 Manufacturing Process Analysis of Neohespiridine
10.4 Industry Chain Structure of Neohespiridine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neohespiridine Distributors
11.3 Neohespiridine Customer
12 World Forecast Review for Neohespiridine by Geographic Region
12.1 Global Neohespiridine Market Size Forecast by Region
12.1.1 Global Neohespiridine Forecast by Region (2024-2029)
12.1.2 Global Neohespiridine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neohespiridine Forecast by Type
12.7 Global Neohespiridine Forecast by Application
13 Key Players Analysis
13.1 DuPont
13.1.1 DuPont Company Information
13.1.2 DuPont Neohespiridine Product Portfolios and Specifications
13.1.3 DuPont Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 DuPont Main Business Overview
13.1.5 DuPont Latest Developments
13.2 Changsha Sunnycare
13.2.1 Changsha Sunnycare Company Information
13.2.2 Changsha Sunnycare Neohespiridine Product Portfolios and Specifications
13.2.3 Changsha Sunnycare Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Changsha Sunnycare Main Business Overview
13.2.5 Changsha Sunnycare Latest Developments
13.3 Biospringer
13.3.1 Biospringer Company Information
13.3.2 Biospringer Neohespiridine Product Portfolios and Specifications
13.3.3 Biospringer Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Biospringer Main Business Overview
13.3.5 Biospringer Latest Developments
13.4 Gelfix
13.4.1 Gelfix Company Information
13.4.2 Gelfix Neohespiridine Product Portfolios and Specifications
13.4.3 Gelfix Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Gelfix Main Business Overview
13.4.5 Gelfix Latest Developments
13.5 CP Kelco
13.5.1 CP Kelco Company Information
13.5.2 CP Kelco Neohespiridine Product Portfolios and Specifications
13.5.3 CP Kelco Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CP Kelco Main Business Overview
13.5.5 CP Kelco Latest Developments
13.6 Kang Biotech
13.6.1 Kang Biotech Company Information
13.6.2 Kang Biotech Neohespiridine Product Portfolios and Specifications
13.6.3 Kang Biotech Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Kang Biotech Main Business Overview
13.6.5 Kang Biotech Latest Developments
13.7 BASF SE
13.7.1 BASF SE Company Information
13.7.2 BASF SE Neohespiridine Product Portfolios and Specifications
13.7.3 BASF SE Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 BASF SE Main Business Overview
13.7.5 BASF SE Latest Developments
13.8 Bordas Distillations Chinchurreta
13.8.1 Bordas Distillations Chinchurreta Company Information
13.8.2 Bordas Distillations Chinchurreta Neohespiridine Product Portfolios and Specifications
13.8.3 Bordas Distillations Chinchurreta Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bordas Distillations Chinchurreta Main Business Overview
13.8.5 Bordas Distillations Chinchurreta Latest Developments
13.9 Golden Health
13.9.1 Golden Health Company Information
13.9.2 Golden Health Neohespiridine Product Portfolios and Specifications
13.9.3 Golden Health Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Golden Health Main Business Overview
13.9.5 Golden Health Latest Developments
13.10 Cargill
13.10.1 Cargill Company Information
13.10.2 Cargill Neohespiridine Product Portfolios and Specifications
13.10.3 Cargill Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Cargill Main Business Overview
13.10.5 Cargill Latest Developments
13.11 Okay Pharmaceutical
13.11.1 Okay Pharmaceutical Company Information
13.11.2 Okay Pharmaceutical Neohespiridine Product Portfolios and Specifications
13.11.3 Okay Pharmaceutical Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Okay Pharmaceutical Main Business Overview
13.11.5 Okay Pharmaceutical Latest Developments
13.12 FMC Health and Nutrition
13.12.1 FMC Health and Nutrition Company Information
13.12.2 FMC Health and Nutrition Neohespiridine Product Portfolios and Specifications
13.12.3 FMC Health and Nutrition Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 FMC Health and Nutrition Main Business Overview
13.12.5 FMC Health and Nutrition Latest Developments
13.13 Nutrafur
13.13.1 Nutrafur Company Information
13.13.2 Nutrafur Neohespiridine Product Portfolios and Specifications
13.13.3 Nutrafur Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Nutrafur Main Business Overview
13.13.5 Nutrafur Latest Developments
13.14 Chr.Hansen Holding A/S
13.14.1 Chr.Hansen Holding A/S Company Information
13.14.2 Chr.Hansen Holding A/S Neohespiridine Product Portfolios and Specifications
13.14.3 Chr.Hansen Holding A/S Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Chr.Hansen Holding A/S Main Business Overview
13.14.5 Chr.Hansen Holding A/S Latest Developments
13.15 Layn
13.15.1 Layn Company Information
13.15.2 Layn Neohespiridine Product Portfolios and Specifications
13.15.3 Layn Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Layn Main Business Overview
13.15.5 Layn Latest Developments
13.16 Corbion NV
13.16.1 Corbion NV Company Information
13.16.2 Corbion NV Neohespiridine Product Portfolios and Specifications
13.16.3 Corbion NV Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Corbion NV Main Business Overview
13.16.5 Corbion NV Latest Developments
13.17 Hanfang
13.17.1 Hanfang Company Information
13.17.2 Hanfang Neohespiridine Product Portfolios and Specifications
13.17.3 Hanfang Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Hanfang Main Business Overview
13.17.5 Hanfang Latest Developments
13.18 Lianyuan Kangbiotech
13.18.1 Lianyuan Kangbiotech Company Information
13.18.2 Lianyuan Kangbiotech Neohespiridine Product Portfolios and Specifications
13.18.3 Lianyuan Kangbiotech Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Lianyuan Kangbiotech Main Business Overview
13.18.5 Lianyuan Kangbiotech Latest Developments
13.19 Firmenich SA
13.19.1 Firmenich SA Company Information
13.19.2 Firmenich SA Neohespiridine Product Portfolios and Specifications
13.19.3 Firmenich SA Neohespiridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Firmenich SA Main Business Overview
13.19.5 Firmenich SA Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Neohespiridine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Neohespiridine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Industrial Grade
Table 4. Major Players of Food Grade
Table 5. Major Players of Pharmacy Grade
Table 6. Global Neohespiridine Sales by Type (2018-2023) & (Kiloton)
Table 7. Global Neohespiridine Sales Market Share by Type (2018-2023)
Table 8. Global Neohespiridine Revenue by Type (2018-2023) & ($ million)
Table 9. Global Neohespiridine Revenue Market Share by Type (2018-2023)
Table 10. Global Neohespiridine Sale Price by Type (2018-2023) & (US$/Ton)
Table 11. Global Neohespiridine Sales by Application (2018-2023) & (Kiloton)
Table 12. Global Neohespiridine Sales Market Share by Application (2018-2023)
Table 13. Global Neohespiridine Revenue by Application (2018-2023)
Table 14. Global Neohespiridine Revenue Market Share by Application (2018-2023)
Table 15. Global Neohespiridine Sale Price by Application (2018-2023) & (US$/Ton)
Table 16. Global Neohespiridine Sales by Company (2018-2023) & (Kiloton)
Table 17. Global Neohespiridine Sales Market Share by Company (2018-2023)
Table 18. Global Neohespiridine Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Neohespiridine Revenue Market Share by Company (2018-2023)
Table 20. Global Neohespiridine Sale Price by Company (2018-2023) & (US$/Ton)
Table 21. Key Manufacturers Neohespiridine Producing Area Distribution and Sales Area
Table 22. Players Neohespiridine Products Offered
Table 23. Neohespiridine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Neohespiridine Sales by Geographic Region (2018-2023) & (Kiloton)
Table 27. Global Neohespiridine Sales Market Share Geographic Region (2018-2023)
Table 28. Global Neohespiridine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Neohespiridine Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Neohespiridine Sales by Country/Region (2018-2023) & (Kiloton)
Table 31. Global Neohespiridine Sales Market Share by Country/Region (2018-2023)
Table 32. Global Neohespiridine Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Neohespiridine Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Neohespiridine Sales by Country (2018-2023) & (Kiloton)
Table 35. Americas Neohespiridine Sales Market Share by Country (2018-2023)
Table 36. Americas Neohespiridine Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Neohespiridine Revenue Market Share by Country (2018-2023)
Table 38. Americas Neohespiridine Sales by Type (2018-2023) & (Kiloton)
Table 39. Americas Neohespiridine Sales by Application (2018-2023) & (Kiloton)
Table 40. APAC Neohespiridine Sales by Region (2018-2023) & (Kiloton)
Table 41. APAC Neohespiridine Sales Market Share by Region (2018-2023)
Table 42. APAC Neohespiridine Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Neohespiridine Revenue Market Share by Region (2018-2023)
Table 44. APAC Neohespiridine Sales by Type (2018-2023) & (Kiloton)
Table 45. APAC Neohespiridine Sales by Application (2018-2023) & (Kiloton)
Table 46. Europe Neohespiridine Sales by Country (2018-2023) & (Kiloton)
Table 47. Europe Neohespiridine Sales Market Share by Country (2018-2023)
Table 48. Europe Neohespiridine Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Neohespiridine Revenue Market Share by Country (2018-2023)
Table 50. Europe Neohespiridine Sales by Type (2018-2023) & (Kiloton)
Table 51. Europe Neohespiridine Sales by Application (2018-2023) & (Kiloton)
Table 52. Middle East & Africa Neohespiridine Sales by Country (2018-2023) & (Kiloton)
Table 53. Middle East & Africa Neohespiridine Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Neohespiridine Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Neohespiridine Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Neohespiridine Sales by Type (2018-2023) & (Kiloton)
Table 57. Middle East & Africa Neohespiridine Sales by Application (2018-2023) & (Kiloton)
Table 58. Key Market Drivers & Growth Opportunities of Neohespiridine
Table 59. Key Market Challenges & Risks of Neohespiridine
Table 60. Key Industry Trends of Neohespiridine
Table 61. Neohespiridine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Neohespiridine Distributors List
Table 64. Neohespiridine Customer List
Table 65. Global Neohespiridine Sales Forecast by Region (2024-2029) & (Kiloton)
Table 66. Global Neohespiridine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Neohespiridine Sales Forecast by Country (2024-2029) & (Kiloton)
Table 68. Americas Neohespiridine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Neohespiridine Sales Forecast by Region (2024-2029) & (Kiloton)
Table 70. APAC Neohespiridine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Neohespiridine Sales Forecast by Country (2024-2029) & (Kiloton)
Table 72. Europe Neohespiridine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Neohespiridine Sales Forecast by Country (2024-2029) & (Kiloton)
Table 74. Middle East & Africa Neohespiridine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Neohespiridine Sales Forecast by Type (2024-2029) & (Kiloton)
Table 76. Global Neohespiridine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Neohespiridine Sales Forecast by Application (2024-2029) & (Kiloton)
Table 78. Global Neohespiridine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. DuPont Basic Information, Neohespiridine Manufacturing Base, Sales Area and Its Competitors
Table 80. DuPont Neohespiridine Product Portfolios and Specifications
Table 81. DuPont Neohespiridine Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 82. DuPont Main Business
Table 83. DuPont Latest Developments
Table 84. Changsha Sunnycare Basic Information, Neohespiridine Manufacturing Base, Sales Area and Its Competitors
Table 85. Changsha Sunnycare Neohespiridine Product Portfolios and Specifications
Table 86. Changsha Sunnycare Neohespiridine Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 87. Changsha Sunnycare Main Business
Table 88. Changsha Sunnycare Latest Developments
Table 89. Biospringer Basic Information, Neohespiridine Manufacturing Base, Sales Area and Its Competitors
Table 90. Biospringer Neohespiridine Product Portfolios and Specifications
Table 91. Biospringer Neohespiridine Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 92. Biospringer Main Business
Table 93. Biospringer Latest Developments
Table 94. Gelfix Basic Information, Neohespiridine Manufacturing Base, Sales Area and Its Competitors
Table 95. Gelfix Neohespiridine Product Portfolios and Specifications
Table 96. Gelfix Neohespiridine Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 97. Gelfix Main Business
Table 98. Gelfix Latest Developments
Table 99. CP Kelco Basic Information, Neohespiridine Manufacturing Base, Sales Area and Its Competitors
Table 100. CP Kelco Neohespiridine Product Portfolios and Specifications
Table 101. CP Kelco Neohespiridine Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 102. CP Kelco Main Business
Table 103. CP Kelco Latest Developments
Table 104. Kang Biotech Basic Information, Neohespiridine Manufacturing Base, Sales Area and Its Competitors
Table 105. Kang Biotech Neohespiridine Product Portfolios and Specifications
Table 106. Kang Biotech Neohespiridine Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 107. Kang Biotech Main Business
Table 108. Kang Biotech Latest Developments
Table 109. BASF SE Basic Information, Neohespiridine Manufacturing Base, Sales Area and Its Competitors
Table 110. BASF SE Neohespiridine Product Portfolios and Specifications
Table 111. BASF SE Neohespiridine Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 112. BASF SE Main Business
Table 113. BASF SE Latest Developments
Table 114. Bordas Distillations Chinchurreta Basic Information, Neohespiridine Manufacturing Base, Sales Area and Its Competitors
Table 115. Bordas Distillations Chinchurreta Neohespiridine Product Portfolios and Specifications
Table 116. Bordas Distillations Chinchurreta Neohespiridine Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 117. Bordas Distillations Chinchurreta Main Business
Table 118. Bordas Distillations Chinchurreta Latest Developments
Table 119. Golden Health Basic Information, Neohespiridine Manufacturing Base, Sales Area and Its Competitors
Table 120. Golden Health Neohespiridine Product Portfolios and Specifications
Table 121. Golden Health Neohespiridine Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 122. Golden Health Main Business
Table 123. Golden Health Latest Developments
Table 124. Cargill Basic Information, Neohespiridine Manufacturing Base, Sales Area and Its Competitors
Table 125. Cargill Neohespiridine Product Portfolios and Specifications
Table 126. Cargill Neohespiridine Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 127. Cargill Main Business
Table 128. Cargill Latest Developments
Table 129. Okay Pharmaceutical Basic Information, Neohespiridine Manufacturing Base, Sales Area and Its Competitors
Table 130. Okay Pharmaceutical Neohespiridine Product Portfolios and Specifications
Table 131. Okay Pharmaceutical Neohespiridine Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 132. Okay Pharmaceutical Main Business
Table 133. Okay Pharmaceutical Latest Developments
Table 134. FMC Health and Nutrition Basic Information, Neohespiridine Manufacturing Base, Sales Area and Its Competitors
Table 135. FMC Health and Nutrition Neohespiridine Product Portfolios and Specifications
Table 136. FMC Health and Nutrition Neohespiridine Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 137. FMC Health and Nutrition Main Business
Table 138. FMC Health and Nutrition Latest Developments
Table 139. Nutrafur Basic Information, Neohespiridine Manufacturing Base, Sales Area and Its Competitors
Table 140. Nutrafur Neohespiridine Product Portfolios and Specifications
Table 141. Nutrafur Neohespiridine Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 142. Nutrafur Main Business
Table 143. Nutrafur Latest Developments
Table 144. Chr.Hansen Holding A/S Basic Information, Neohespiridine Manufacturing Base, Sales Area and Its Competitors
Table 145. Chr.Hansen Holding A/S Neohespiridine Product Portfolios and Specifications
Table 146. Chr.Hansen Holding A/S Neohespiridine Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 147. Chr.Hansen Holding A/S Main Business
Table 148. Chr.Hansen Holding A/S Latest Developments
Table 149. Layn Basic Information, Neohespiridine Manufacturing Base, Sales Area and Its Competitors
Table 150. Layn Neohespiridine Product Portfolios and Specifications
Table 151. Layn Neohespiridine Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 152. Layn Main Business
Table 153. Layn Latest Developments
Table 154. Corbion NV Basic Information, Neohespiridine Manufacturing Base, Sales Area and Its Competitors
Table 155. Corbion NV Neohespiridine Product Portfolios and Specifications
Table 156. Corbion NV Neohespiridine Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 157. Corbion NV Main Business
Table 158. Corbion NV Latest Developments
Table 159. Hanfang Basic Information, Neohespiridine Manufacturing Base, Sales Area and Its Competitors
Table 160. Hanfang Neohespiridine Product Portfolios and Specifications
Table 161. Hanfang Neohespiridine Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 162. Hanfang Main Business
Table 163. Hanfang Latest Developments
Table 164. Lianyuan Kangbiotech Basic Information, Neohespiridine Manufacturing Base, Sales Area and Its Competitors
Table 165. Lianyuan Kangbiotech Neohespiridine Product Portfolios and Specifications
Table 166. Lianyuan Kangbiotech Neohespiridine Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 167. Lianyuan Kangbiotech Main Business
Table 168. Lianyuan Kangbiotech Latest Developments
Table 169. Firmenich SA Basic Information, Neohespiridine Manufacturing Base, Sales Area and Its Competitors
Table 170. Firmenich SA Neohespiridine Product Portfolios and Specifications
Table 171. Firmenich SA Neohespiridine Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 172. Firmenich SA Main Business
Table 173. Firmenich SA Latest Developments
List of Figures
Figure 1. Picture of Neohespiridine
Figure 2. Neohespiridine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neohespiridine Sales Growth Rate 2018-2029 (Kiloton)
Figure 7. Global Neohespiridine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Neohespiridine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Industrial Grade
Figure 10. Product Picture of Food Grade
Figure 11. Product Picture of Pharmacy Grade
Figure 12. Global Neohespiridine Sales Market Share by Type in 2022
Figure 13. Global Neohespiridine Revenue Market Share by Type (2018-2023)
Figure 14. Neohespiridine Consumed in Food
Figure 15. Global Neohespiridine Market: Food (2018-2023) & (Kiloton)
Figure 16. Neohespiridine Consumed in Medicine
Figure 17. Global Neohespiridine Market: Medicine (2018-2023) & (Kiloton)
Figure 18. Neohespiridine Consumed in Chemical
Figure 19. Global Neohespiridine Market: Chemical (2018-2023) & (Kiloton)
Figure 20. Neohespiridine Consumed in Cosmetics
Figure 21. Global Neohespiridine Market: Cosmetics (2018-2023) & (Kiloton)
Figure 22. Neohespiridine Consumed in Other
Figure 23. Global Neohespiridine Market: Other (2018-2023) & (Kiloton)
Figure 24. Global Neohespiridine Sales Market Share by Application (2022)
Figure 25. Global Neohespiridine Revenue Market Share by Application in 2022
Figure 26. Neohespiridine Sales Market by Company in 2022 (Kiloton)
Figure 27. Global Neohespiridine Sales Market Share by Company in 2022
Figure 28. Neohespiridine Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Neohespiridine Revenue Market Share by Company in 2022
Figure 30. Global Neohespiridine Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Neohespiridine Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Neohespiridine Sales 2018-2023 (Kiloton)
Figure 33. Americas Neohespiridine Revenue 2018-2023 ($ Millions)
Figure 34. APAC Neohespiridine Sales 2018-2023 (Kiloton)
Figure 35. APAC Neohespiridine Revenue 2018-2023 ($ Millions)
Figure 36. Europe Neohespiridine Sales 2018-2023 (Kiloton)
Figure 37. Europe Neohespiridine Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Neohespiridine Sales 2018-2023 (Kiloton)
Figure 39. Middle East & Africa Neohespiridine Revenue 2018-2023 ($ Millions)
Figure 40. Americas Neohespiridine Sales Market Share by Country in 2022
Figure 41. Americas Neohespiridine Revenue Market Share by Country in 2022
Figure 42. Americas Neohespiridine Sales Market Share by Type (2018-2023)
Figure 43. Americas Neohespiridine Sales Market Share by Application (2018-2023)
Figure 44. United States Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Neohespiridine Sales Market Share by Region in 2022
Figure 49. APAC Neohespiridine Revenue Market Share by Regions in 2022
Figure 50. APAC Neohespiridine Sales Market Share by Type (2018-2023)
Figure 51. APAC Neohespiridine Sales Market Share by Application (2018-2023)
Figure 52. China Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Neohespiridine Sales Market Share by Country in 2022
Figure 60. Europe Neohespiridine Revenue Market Share by Country in 2022
Figure 61. Europe Neohespiridine Sales Market Share by Type (2018-2023)
Figure 62. Europe Neohespiridine Sales Market Share by Application (2018-2023)
Figure 63. Germany Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Neohespiridine Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Neohespiridine Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Neohespiridine Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Neohespiridine Sales Market Share by Application (2018-2023)
Figure 72. Egypt Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Neohespiridine Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Neohespiridine in 2022
Figure 78. Manufacturing Process Analysis of Neohespiridine
Figure 79. Industry Chain Structure of Neohespiridine
Figure 80. Channels of Distribution
Figure 81. Global Neohespiridine Sales Market Forecast by Region (2024-2029)
Figure 82. Global Neohespiridine Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Neohespiridine Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Neohespiridine Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Neohespiridine Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Neohespiridine Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のネオヘスピリジン市場予測 2023年-2029年(Global Neohespiridine Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆